{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:27:56Z","timestamp":1787243276684,"version":"build-2736575974"},"reference-count":72,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["88882.436160\/2019-01"],"award-info":[{"award-number":["88882.436160\/2019-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["408879\/2018-1"],"award-info":[{"award-number":["408879\/2018-1"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["306947\/2020-0"],"award-info":[{"award-number":["306947\/2020-0"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["408879\/2018-1"],"award-info":[{"award-number":["408879\/2018-1"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["88882.436160\/2019-01"],"award-info":[{"award-number":["88882.436160\/2019-01"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["408879\/2018-1"],"award-info":[{"award-number":["408879\/2018-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["306947\/2020-0"],"award-info":[{"award-number":["306947\/2020-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["408879\/2018-1"],"award-info":[{"award-number":["408879\/2018-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"abstract":"<jats:p>Abstract The highly lipophilic nature and low aqueous solubility of cannabidiol (CBD) limit its oral bioavailability, resulting in poor intestinal absorption. To overcome these limitations, we proposed the production of a nanoemulsion with CBD to be included in the therapeutic treatment of autism spectrum disorder. The current study aimed to evaluate the effect of CBD-rich corn oil nanoemulsion treatment in male rats born to females exposed to valproic acid (VPA) during pregnancy on autistic-like behaviors and hippocampal histology. Offspring rats were treated orally twice daily with CBD nanoemulsions at different doses (1 and 2 mg\/animal). The endpoints evaluated were anxiety, grooming time, exploratory activity, sociability, the social preference index, and hippocampal and cerebral cortex histology. All formulations were characterized as nanoemulsions and showed a reduced vesicle size (107.6 - 72.6 nm), low PDI (0.290-0.432), negative zeta potential (-40.6 mv), and good stability. Prenatal exposure to VPA increased anxiety and grooming time, and reduced exploratory activity, sociability, and the social preference index in the animals. Furthermore, VPA-exposed animals exhibited elevated neuronal death and a reduction in viable cells in the hippocampus. In conclusion, CBD nanoemulsion treatment reversed autistic-like behaviors, potentially by protecting against hippocampal neuronal death. The highly lipophilic nature and low aqueous solubility of cannabidiol (CBD) limit its oral bioavailability, resulting in poor intestinal absorption. To overcome these limitations, we proposed the production of a nanoemulsion with CBD to be included in the therapeutic treatment of autism spectrum disorder. The current study aimed to evaluate the effect of CBD-rich corn oil nanoemulsion treatment in male rats born to females exposed to valproic acid (VPA) during pregnancy on autistic-like behaviors and hippocampal histology. Offspring rats were treated orally twice daily with CBD nanoemulsions at different doses (1 and 2 mg\/animal). The endpoints evaluated were anxiety, grooming time, exploratory activity, sociability, the social preference index, and hippocampal and cerebral cortex histology. All formulations were characterized as nanoemulsions and showed a reduced vesicle size (107.6 - 72.6 nm), low PDI (0.290-0.432), negative zeta potential (-40.6 mv), and good stability. Prenatal exposure to VPA increased anxiety and grooming time, and reduced exploratory activity, sociability, and the social preference index in the animals. Furthermore, VPA-exposed animals exhibited elevated neuronal death and a reduction in viable cells in the hippocampus. In conclusion, CBD nanoemulsion treatment reversed autistic-like behaviors, potentially by protecting against hippocampal neuronal death.<\/jats:p>","DOI":"10.1590\/0001-3765202520240607","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:52:54Z","timestamp":1738907574000},"source":"Crossref","is-referenced-by-count":4,"title":["Nanoemulsions with cannabidiol reduced autistic-like behaviors and reversed decreased hippocampus viable cells and cerebral cortex neuronal death in a prenatal valproic acid rat model"],"prefix":"10.1590","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-3679","authenticated-orcid":false,"given":"MARIANA DE F.O. DA","family":"SILVA","sequence":"first","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-3511","authenticated-orcid":false,"given":"AMANDA R.","family":"SANTOS-MAGNABOSCO","sequence":"additional","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-8731","authenticated-orcid":false,"given":"CL\u00c1UDIA KATHARINY DA S.","family":"FARIAS","sequence":"additional","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5468-8478","authenticated-orcid":false,"given":"SANDRA MARIA DE","family":"TORRES","sequence":"additional","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-6931","authenticated-orcid":false,"given":"ANT\u00d4NIO JOS\u00c9","family":"ALVES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5872","authenticated-orcid":false,"given":"PABYTON G.","family":"CADENA","sequence":"additional","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-7337","authenticated-orcid":false,"given":"VALDEMIRO A. DA","family":"SILVA J\u00daNIOR","sequence":"additional","affiliation":[{"name":"Universidade Federal Rural de Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","series-title":"Guia de estabilidade de produtos cosm\u00e9ticos, Brasilia, Brazil","year":"2004"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00424","article-title":"The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism","volume":"13","author":"ARAUJO DJ","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"ref3","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th ed","author":"ASSOCIATION AP","year":"2013"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and Anti-Inflammatory Properties of Cannabidiol","volume":"9","author":"ATALAY S","year":"2019","journal-title":"Antioxidants"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2021.08.005","article-title":"Hippocampal contributions to social and cognitive deficits in autism spectrum disorder","volume":"44","author":"BANKER SM","year":"2021","journal-title":"Trends Neurosci"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37570-y","article-title":"Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy","volume":"9","author":"BAR-LEV SCHLEIDER L","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1038\/s41380-021-01227-6","article-title":"Oxytocin administration in neonates shapes hippocampal circuitry and restores social behavior in a mouse model of autism","volume":"26","author":"BERTONI A","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.chc.2020.02.002","article-title":"Seizures and Epilepsy in Autism Spectrum Disorder","volume":"29","author":"BESAG FMC","year":"2020","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"BISOGNO T","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref10","first-page":"236","article-title":"The valproate model of autism","volume":"35","author":"BOSSU JL","year":"2019","journal-title":"Med Sci (Paris)"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102478","article-title":"Cannabinoid Delivery Systems for Pain and Inflammation Treatment","volume":"23","author":"BRUNI N","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/17460441.2018.1463988","article-title":"Computational modeling of human oral bioavailability: what will be next","volume":"13","author":"CABRERA-PEREZ MA","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbamem.2012.10.022","article-title":"Nanoencapsulation of quercetin and resveratrol into elastic liposomes","volume":"1828","author":"CADENA PG","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.12.009","article-title":"Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story","volume":"121","author":"CARBONE E","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"ref15","article-title":"Valproate reduces neuroinflammation and neuronal death in a rat chronic constriction injury model","volume":"8","author":"CHEN JY","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10068-019-00731-4","article-title":"Nanoemulsions as delivery systems for lipophilic nutraceuticals: strategies for improving their formulation, stability, functionality and bioavailability","volume":"29","author":"CHOI SJ","year":"2020","journal-title":"Food Sci Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijpharm.2019.05.042","article-title":"Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting","volume":"565","author":"CHOUDHURY H","year":"2019","journal-title":"Int J Pharm"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000375489","article-title":"Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism","volume":"37","author":"CODAGNONE MG","year":"2015","journal-title":"Dev Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems","volume":"10","author":"DANAEI M","year":"2018","journal-title":"Pharmaceutics"},{"key":"ref20","article-title":"Development, Characterization, and Immunomodulatory Evaluation of Carvacrol-loaded Nanoemulsion","volume":"26","author":"DANTAS AGB","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour","volume":"219","author":"DEIANA S","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"ref22","first-page":"189","article-title":"The role of cannabinoids in neurodevelopmental disorders of children and adolescents","volume":"75","author":"DIAS-DE FREITAS F","year":"2022","journal-title":"Rev Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.msec.2014.12.012","article-title":"Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study","volume":"48","author":"ESPOSITO E","year":"2015","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1523\/JNEUROSCI.4257-13.2014","article-title":"Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior","volume":"34","author":"FELIX-ORTIZ AC","year":"2014","journal-title":"J Neurosci"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1172\/JCI131752","article-title":"An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability","volume":"130","author":"FOLKES OM","year":"2020","journal-title":"J Clin Invest"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/aur.2520","article-title":"Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-alpha, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL\/J mice","volume":"14","author":"FYKE W","year":"2021","journal-title":"Autism Res"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/aur.2562","article-title":"Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder","volume":"14","author":"FYKE W","year":"2021","journal-title":"Autism Res"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02204-0","article-title":"Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder","volume":"18","author":"GALVANI G","year":"2021","journal-title":"J Neuroinflammation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature13028","article-title":"The hippocampal CA2 region is essential for social memory","volume":"508","author":"HITTI FL","year":"2014","journal-title":"Nature"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","article-title":"Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC","volume":"27","author":"HLOZEK T","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/1570159X18666200620230321","article-title":"Crosstalk between Inflammation and the BBB in Stroke","volume":"18","author":"HUANG Y","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"42","key":"ref32","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"KAPLAN JS","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11060762","article-title":"Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model","volume":"11","author":"KELLER R","year":"2021","journal-title":"Brain Sciences"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","article-title":"Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid","volume":"113","author":"KERR DM","year":"2016","journal-title":"Pharmacol Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8994-2_4","article-title":"The Elevated Plus Maze Test for Measuring Anxiety-Like Behavior in Rodents","volume":"1916","author":"KRAEUTER AK","year":"2019","journal-title":"Methods Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jnr.23948","article-title":"Imaging sex\/gender and autism in the brain: Etiological implications","volume":"95","author":"LAI MC","year":"2017","journal-title":"J Neurosci Res"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040514","article-title":"Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson\u2019s Rats","volume":"16","author":"LAPMANEE S","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"LORD C","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues","volume":"106","author":"LUNDQUIST P","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107176","article-title":"Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors","volume":"203","author":"MANDUCA A","year":"2024","journal-title":"Pharmacol Res"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101081","article-title":"Advances in edible nanoemulsions: Digestion, bioavailability, and potential toxicity","volume":"81","author":"MCCLEMENTS DJ","year":"2021","journal-title":"Prog Lipid Res"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","DOI":"10.3390\/foods10020365","article-title":"Utilization of Nanotechnology to Improve the Handling, Storage and Biocompatibility of Bioactive Lipids in Food Applications","volume":"10","author":"MCCLEMENTS DJ","year":"2021","journal-title":"Foods"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112966","article-title":"Valproic acid treated female Long-Evans rats are impaired on attentional set-shifting","volume":"397","author":"MCKINNELL ZE","year":"2021","journal-title":"Behav Brain Res"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12031-022-02033-7","article-title":"Critical Evaluation of Valproic Acid-Induced Rodent Models of Autism: Current and Future Perspectives","volume":"72","author":"MEHRA S","year":"2022","journal-title":"J Mol Neurosci"},{"issue":"18","key":"ref45","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"MELANCIA F","year":"2018","journal-title":"Br J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.foodres.2018.09.004","article-title":"Improved absorption of beta-carotene by encapsulation in an oil-in-water nanoemulsion containing tea polyphenols in the aqueous phase","volume":"116","author":"MENG Q","year":"2019","journal-title":"Food Res Int"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050700","article-title":"Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions","volume":"22","author":"MIKULCOVA V","year":"2017","journal-title":"Molecules"},{"key":"ref48","first-page":"199","author":"MOHAMMADI S","year":"2020"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-05422-3","article-title":"Cannabidiol (Epidyolex(R)) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials","volume":"24","author":"MULLER AR","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000497361","article-title":"Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol","volume":"2","author":"NAKANO Y","year":"2019","journal-title":"Med Cannabis Cannabinoids"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs","volume":"14","author":"NAQVI S","year":"2020","journal-title":"Front Neurosci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"NICOLINI C","year":"2018","journal-title":"Exp Neurol"},{"key":"ref53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173607","article-title":"A systematic review of cannabidiol trials in neurodevelopmental disorders","volume":"230","author":"PARRELLA NF","year":"2023","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-022-06196-4","article-title":"Cannabidiol for the treatment of autism spectrum disorder: hope or hype","volume":"239","author":"PEDRAZZI JFC","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pnpbp.2018.08.030","article-title":"Cannabidiol as a suggested candidate for treatment of autism spectrum disorder","volume":"89","author":"POLEG S","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10695-022-01156-3","article-title":"Testosterone nanoemulsion produced masculinized Nile tilapia (Oreochromis niloticus)","volume":"48","author":"SANTOS-MAGNABOSCO AR","year":"2022","journal-title":"Fish Physiol Biochem"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"SCHNEIDER T","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0795-y","article-title":"Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism","volume":"193","author":"SCHNEIDER T","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"48","key":"ref59","doi-asserted-by":"crossref","first-page":"33122","DOI":"10.1021\/acsomega.1c05490","article-title":"Effect of the Zeta Potential on the Corrosion Resistance of Electroless Nickel and PVDF Composite Layers Using Surfactants","volume":"6","author":"SHEN X","year":"2021","journal-title":"ACS Omega"},{"key":"ref60","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1359810","article-title":"Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism","volume":"18","author":"SHRADER SH","year":"2024","journal-title":"Front Neurosci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: Concepts, development and applications in drug delivery","volume":"252","author":"SINGH Y","year":"2017","journal-title":"J Control Release"},{"issue":"24","key":"ref62","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"SMITH MC","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1185737","article-title":"Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder","volume":"17","author":"STABEN J","year":"2023","journal-title":"Front Neurosci"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111322","article-title":"Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment","volume":"137","author":"TALEB A","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2018.12.024","article-title":"Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder","volume":"159","author":"TARTAGLIONE AM","year":"2019","journal-title":"Neuropharmacology"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/02652048.2015.1065917","article-title":"Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability","volume":"32","author":"THAKKAR HP","year":"2015","journal-title":"J Microencapsul"},{"key":"ref67","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26123720","article-title":"Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid","volume":"26","author":"THORNTON AM","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"ref68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18773\/austprescr.2020.054","article-title":"The role of drugs in the treatment of autism","volume":"43","author":"TURNER M","year":"2020","journal-title":"Australian Prescriber"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jnc.15444","article-title":"Neurobiological substrates underlying corpus callosum hypoconnectivity and brain metabolic patterns in the valproic acid rat model of autism spectrum disorder","volume":"159","author":"UCCELLI NA","year":"2021","journal-title":"J Neurochem"},{"issue":"12","key":"ref70","first-page":"2796","article-title":"Increased Expression of Kv10","volume":"44","author":"WANG J","year":"2019","journal-title":"Neurochem Res"},{"key":"ref71","article-title":"Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism","volume":"162","author":"WU HF","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref72","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00367","article-title":"Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats","volume":"13","author":"ZAMBERLETTI E","year":"2019","journal-title":"Front Cell Neurosci"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0001-37652025000101301&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:53:38Z","timestamp":1738907618000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652025000101301&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S0001-37652025000101301"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765202520240607","relation":{},"ISSN":["1678-2690","0001-3765"],"issn-type":[{"value":"1678-2690","type":"electronic"},{"value":"0001-3765","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e20240607"}}